Back
Sunshine Biopharma, Inc. 10K Form
Sell
22
SBFM
Sunshine Biopharma, Inc.
Last Price:
$1.44
Seasonality Move:
86.56%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SBFM News And Ratings
See the #1 stock for the next 7 days that we like better than SBFM
SBFM Financial Statistics
Sales & Book Value
| Annual Sales: | $34.9M |
|---|---|
| Cash Flow: | $-761.9K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.31 |
| Price / Book: | 0.29 |
Profitability
| EPS (TTM): | -1.86080 |
|---|---|
| Net Income (TTM): | $-6M |
| Gross Margin: | $10.4M |
| Return on Equity: | -24.74% |
| Return on Assets: | -19.55% |
Sunshine Biopharma, Inc. Earnings Forecast
Key Sunshine Biopharma, Inc. Financial Ratios
-
The Gross Profit Margin over the past 18 years for SBFM is 29.95%.
-
The Selling, General & Administrative Expenses for SBFM have been equal to 47.26% of Gross Profit Margin.
-
The Research & Development expenses have been 2.68% of Revenue.
-
The Net Earning history of SBFM is -14.72% of Total Revenues.
-
Per Share Earnings over the last 18 years have been positive in 11 years.
Sunshine Biopharma, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SBFM |
| Website: | sunshinebiopharma.com |
Debt
| Debt-to-Equity Ratio: | 0.04 |
|---|---|
| Current Ratio: | 4.2 |
| Quick Ratio: | 2.02 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SBFM Technical Analysis vs Fundamental Analysis
Sell
22
Sunshine Biopharma, Inc. (SBFM)
is a Sell
Is Sunshine Biopharma, Inc. a Buy or a Sell?
-
Sunshine Biopharma, Inc. stock is rated a SellThe current Sunshine Biopharma, Inc. [SBFM] share price is $1.43. The Score for SBFM is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.